GoodCap
1 known investors
Find your way into GoodCap
106 people in our graph share verified history with the GoodCap team — schools, employers, funds. One of them is your warm intro.
Xavier Pétersunlockedknows Darryl Hudson · together at The University of Lethbridge (overlapped)
×9knows the team · via University of Guelph
knows the team · via The University of Lethbridge
knows the team · via Mitacs
GoodCap Pharmaceuticals develops drug candidates targeting disorders driven by neuroinflammation, with a lead candidate (GCAP001) combining two molecule classes to reduce inflammatory biomarkers linked to psychiatric and neurodegenerative conditions. Its initial focus is on treating PTSD.
Founders & leadership
DH
Darryl HudsoninCo-founderDarryl Hudson holds a PhD in Molecular Biology and Genetics and has worked on drug development for inflammation and mental health products. He is co-founder of GoodCap Pharmaceuticals, which develops drug candidates targeting neuroinflammation-driven disorders.
Investors · 1
Frequently asked questions
- What does GoodCap do?
- GoodCap Pharmaceuticals develops drug candidates targeting disorders driven by neuroinflammation, with a lead candidate (GCAP001) combining two molecule classes to reduce inflammatory biomarkers linked to psychiatric and neurodegenerative conditions. Its initial focus is on treating PTSD.
- Who founded GoodCap?
- GoodCap was founded by Darryl Hudson.
- Who are GoodCap's investors?
- GoodCap's investors include JLS.